Good afternoon and welcome to Markets Desk, your midday read on the stories moving money right now.
Boeing is catching a serious bid this session, up close to three percent in premarket after the U.S. Navy selected the aerospace giant to develop its next-generation fighter jet. The timing matters — the company had been staring down the very real risk of losing all fighter production entirely, making this contract a meaningful lifeline for its defense business.
Shifting to biotech, several names punched to fifty-two week highs in today's session, with Iovance Biotherapeutics leading the charge at thirty-one percent. Clinical trial catalysts and revised guidance are driving the moves across names including Xeris, Grail, AbCellera, and Sight Sciences — a reminder that in this corner of the market, a single data readout can reprice a stock entirely in a single session.
And a story with longer-term implications for American research and talent — billionaire Ken Griffin has pledged three billion dollars to Carnegie Mellon University, described by the school as the largest individual gift in the history of higher education. The donation backs plans for a Miami campus and signals continued private capital flowing into the institutions shaping the next generation of technology and science.
That's the tape. Markets Desk, signing off the floor.
